Cargando…

A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment

Objectives: To establish an individualized nomogram to predict the probability of drug-induced liver injury (DILI) in tuberculosis patients receiving anti-tuberculosis treatment. Methods: The clinical information of patients admitted to a tertiary hospital between January 2010 and December 2022 was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Songjun, Lu, Bin, Pan, Xinling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232814/ https://www.ncbi.nlm.nih.gov/pubmed/37274095 http://dx.doi.org/10.3389/fphar.2023.1153815

Ejemplares similares

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis
por: Zhong, Tao, et al.
Publicado: (2021)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway
por: Bai, Zijun, et al.
Publicado: (2022)

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
por: Zhou, Yitian, et al.
Publicado: (2019)

External Validation of a Nomogram and Risk Grouping System for Predicting Individual Prognosis of Patients With Medulloblastoma
por: Guo, Chengcheng, et al.
Publicado: (2020)

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)
por: Ke, Lixin, et al.
Publicado: (2020)

HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
por: Petros, Zelalem, et al.
Publicado: (2017)

Development of a Nomogram for Predicting Mortality Risk in Sepsis Patients During Hospitalization: A Retrospective Study
por: Lu, Bin, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Predicting Drug-Induced Acute Kidney Injury in Hospitalized Patients: A Case-Control Study Based on Propensity-Score Matching
por: Yu, Chengxuan, et al.
Publicado: (2021)

An Individualized Nomogram for Predicting Mortality Risk of Septic Shock Patients During Hospitalization: A ten Years Retrospective Analysis
por: Wang, Mengqi, et al.
Publicado: (2023)

1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
por: Acosta, Carina, et al.
Publicado: (2022)

Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors
por: Adeluwa, Temidayo, et al.
Publicado: (2021)

The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study
por: Li, Zhong-Bin, et al.
Publicado: (2021)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury
por: Yang, Ruiyuan, et al.
Publicado: (2022)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
por: Xiong, Yu-Ting, et al.
Publicado: (2023)

The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China
por: Tuohutaerbieke, Maermaer, et al.
Publicado: (2021)

Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis
por: Rajput, Amarjitsing, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
por: Alffenaar, Jan-Willem C., et al.
Publicado: (2022)

Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients
por: Chen, Qin, et al.
Publicado: (2022)

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
por: Wang, Shuting, et al.
Publicado: (2018)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Auranofin, an Anti-rheumatic Gold Drug, Aggravates the Radiation-Induced Acute Intestinal Injury in Mice
por: Lee, Eun Sang, et al.
Publicado: (2019)

Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19
por: Gao, Suyu, et al.
Publicado: (2022)

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
por: Rivera, Patricia, et al.
Publicado: (2017)

Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice
por: Zhao, Tian-Ming, et al.
Publicado: (2020)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
por: Fu, Siyu, et al.
Publicado: (2020)

The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
por: Liu, Wenhui, et al.
Publicado: (2021)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review
por: Björnsson, Einar S., et al.
Publicado: (2022)

Systems Pharmacology Study of the Anti-Liver Injury Mechanism of Citri Reticulatae Pericarpium
por: Wu, Jianxiong, et al.
Publicado: (2021)

Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
por: Raschi, Emanuel, et al.
Publicado: (2019)

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
por: Zhou, Zhi-Xuan, et al.
Publicado: (2022)

Prediction and associated factors of non-steroidal anti-inflammatory drugs efficacy in migraine treatment
por: Lu, Zhao-Xuan, et al.
Publicado: (2022)

Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations
por: Cheng, Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h42dehsc69ddo93aa2m4r3rcd5